F0605 F605: Prevent the use of unnecessary psychotropic medications or use medications that may restrain a resident's ability to function.
E

Lack of Monitoring for Psychotropic Medication Effectiveness and Adverse Effects

Galion Meadows Skilled Nursing And RehabilitationGalion, Ohio Survey Completed on 05-26-2026

Summary

The facility failed to ensure adequate monitoring for psychotropic medication effectiveness and adverse effects for five residents reviewed for unnecessary medications. The report identified 43 residents receiving psychotropic medications in a census of 55. Facility records, including care plans, physician orders, MARs, TARs, and progress notes, showed that monitoring for adverse effects and effectiveness was expected in the care plans, but there was no documented monitoring in the clinical record for the residents reviewed. Resident #8 had diagnoses including dementia with behavioral disturbance, psychotic disturbance, atrial fibrillation, altered mental status, and cerebral infarction. The resident had orders for mirtazapine, olanzapine, and later buspirone, and the care plan directed staff to monitor and report adverse effects of antidepressant, antianxiety, and antipsychotic medications. However, review of the progress notes, MAR, and TAR from admission through 05/18/26 showed no documentation of monitoring for adverse effects or efficacy, and the DON verified there was no such documentation. Resident #17 had Alzheimer's disease, nontraumatic subdural hemorrhage, anxiety disorder, and major depressive disorder, with severe cognitive impairment and substantial to maximal assistance needs; the resident received buspirone and mirtazapine, but the MAR and TAR showed no monitoring for side effects of the antidepressant or antianxiety medication. Resident #59 had depression, anxiety, and epilepsy, with cognitive impairment and orders for cariprazine, sertraline, and benztropine; the MAR and TAR showed no monitoring for side effects of antidepressant or antipsychotic medication. Resident #05 had severe vascular dementia with behavioral disturbance, dysphasia, diabetes, major depressive disorder, generalized anxiety disorder, and CKD stage 3B, and received ziprasidone as ordered, but the MAR showed no indication that nurses tracked response, effectiveness, adverse effects, or side effects. Resident #31 had pulmonary embolism, emphysema, COPD, and asthma, was cognitively intact with no behaviors identified, and received lurasidone daily; the MAR showed no documented monitoring for effectiveness, adverse effects, or side effects. Facility policy required documentation of adverse reactions and responses to medications, and the psychotropics policy stated psychotropic medications would be evaluated and monitored, with adverse reactions monitored according to the resident plan of care.

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Resources

Below are regulatory guidelines relevant to this citation:

See other F0605 citations
PRN Antipsychotic Order Not Limited or Reassessed
D
F0605 F605: Prevent the use of unnecessary psychotropic medications or use medications that may restrain a resident's ability to function.
Short Summary

PRN Antipsychotic Order Not Limited or Reassessed: A resident with advanced dementia, Alzheimer’s disease, agitation, and hospice services received PRN haloperidol for agitation and delirium under an open-ended order rather than a 14-day limit. Physician documentation continued the medication but did not show an evaluation of its ongoing need or an adequate rationale for renewal, and nursing notes did not document non-pharmacological interventions before one PRN dose was given.

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.
Lack of Behavior Monitoring for Antipsychotic Use
D
F0605 F605: Prevent the use of unnecessary psychotropic medications or use medications that may restrain a resident's ability to function.
Short Summary

A resident with depression and delusional disorders was prescribed Olanzapine for delusions, but the MAR and care plan showed no targeted behavior monitoring or other behavioral documentation to support the medication’s use or effectiveness. The SS Director and DNS both confirmed the resident was not on behavior monitoring, despite the facility stating residents on antipsychotics were placed on it.

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.
Antipsychotic Use Lacked Documented Diagnosis Support
D
F0605 F605: Prevent the use of unnecessary psychotropic medications or use medications that may restrain a resident's ability to function.
Short Summary

A resident with severe dementia and behavioral symptoms received Seroquel with multiple dose increases, but the orders did not include a documented diagnosis to justify use or escalation. The chart showed dementia, agitation, and later psychosis documentation, while staff described the resident as generally directable and pleasant with more evening behaviors. The resident also had falls during the stay, including one that led to ER transfer.

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.
PRN Lorazepam Lacked Required Stop Date and Rationale
D
F0605 F605: Prevent the use of unnecessary psychotropic medications or use medications that may restrain a resident's ability to function.
Short Summary

A resident with anxiety, restlessness, agitation, and moderately impaired cognition received PRN lorazepam for anxiety, but the order had no stop date and the EHR lacked a documented duration with physician rationale for continued use. The psychotropic care plan did not address the PRN lorazepam, and an RN verified the facility had not obtained the required 14-day stop date or documentation for ongoing use.

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.
Incomplete Psychotropic Behavior Monitoring and Orthostatic BP Documentation
D
F0605 F605: Prevent the use of unnecessary psychotropic medications or use medications that may restrain a resident's ability to function.
Short Summary

Incomplete Psychotropic Monitoring Documentation: The facility did not complete or accurately document monthly behavior summaries for a resident receiving Ativan, quetiapine, risperidone, and sertraline, and another resident’s behavior summary for lurasidone HCl and fluoxetine HCl was inaccurate compared with the MAR. The same resident also lacked complete orthostatic BP monitoring documentation, as the required sitting readings were not recorded within the appropriate time frame. The SSD and DON verified the missing and incorrect documentation.

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.
Psychotropic Medication Consent and GDR Documentation Failure
E
F0605 F605: Prevent the use of unnecessary psychotropic medications or use medications that may restrain a resident's ability to function.
Short Summary

A resident with CVA and dementia, and severe cognitive impairment, received trazodone for depression without a completed medication consent form before the medication was administered. The record also showed a pharmacist-recommended GDR was declined with documentation that family routinely declines GDRs, but the rationale did not state that a further dose reduction would likely impair function or cause psychiatric instability, as required.

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.
Citation search

Search every citation & Plan of Correction

Go to search
Citation watch

Track new serious citations across Ohio

Get a heads-up on the newest immediate-jeopardy (J–L) citations in Ohio — where surveyors are focused right now.

Free · about one email a month

Trusted data from CMS and state health departments

Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release October 8, 2026) and official state health department websites — never guesswork.

In your survey window? See what surveyors are citing.

The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.

Get the Survey-Prep Report
An unhandled error has occurred. Reload 🗙

Connection lost — reconnecting… We couldn't reconnect automatically. Please reload the page to continue.